EP0489300A3 - New tetralones with pharmacological activity - Google Patents
New tetralones with pharmacological activity Download PDFInfo
- Publication number
- EP0489300A3 EP0489300A3 EP19910119718 EP91119718A EP0489300A3 EP 0489300 A3 EP0489300 A3 EP 0489300A3 EP 19910119718 EP19910119718 EP 19910119718 EP 91119718 A EP91119718 A EP 91119718A EP 0489300 A3 EP0489300 A3 EP 0489300A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- tetralones
- new
- pharmacological activity
- pharmacological
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9003308A ES2024969A6 (en) | 1990-12-05 | 1990-12-05 | Process for obtaining tetralones |
ES9003308 | 1990-12-05 | ||
ES9101242A ES2033576B1 (en) | 1991-05-09 | 1991-05-09 | NEW PROCEDURE FOR OBTAINING NEW TETRALONAS. |
ES9101242 | 1991-05-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0489300A2 EP0489300A2 (en) | 1992-06-10 |
EP0489300A3 true EP0489300A3 (en) | 1993-03-17 |
Family
ID=26154508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910119718 Ceased EP0489300A3 (en) | 1990-12-05 | 1991-11-19 | New tetralones with pharmacological activity |
Country Status (4)
Country | Link |
---|---|
US (1) | US5208246A (en) |
EP (1) | EP0489300A3 (en) |
JP (1) | JPH07113014B2 (en) |
CA (1) | CA2056922A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352777A (en) * | 1990-12-26 | 1994-10-04 | Pioneer Hi-Bred International, Inc. | DNA isolation from animal cells |
JP3042156B2 (en) * | 1992-02-20 | 2000-05-15 | 田辺製薬株式会社 | Naphthalene derivative, its production method and its synthetic intermediate |
ES2064228B1 (en) * | 1992-10-19 | 1995-09-01 | Uriach & Cia Sa J | NEW TETRALONES WITH PHARMACOLOGICAL ACTIVITY, COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION. |
US5500442A (en) * | 1994-06-10 | 1996-03-19 | American Home Products Corporation | Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
WO2005082343A2 (en) | 2004-02-25 | 2005-09-09 | La Jolla Pharmaceutical Company | Amines and amides for the treatment of diseases |
CN111333613A (en) * | 2020-01-08 | 2020-06-26 | 上海孜岚医药科技有限公司 | Preparation method of trifluoromethyl tetralone compound |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0168619A1 (en) * | 1984-06-12 | 1986-01-22 | Beecham Group Plc | N-acylated di- or tetrahydronaphthalenamines, and antihypertensive compositions containing them |
EP0321175A1 (en) * | 1987-12-14 | 1989-06-21 | Beecham Group Plc | Indane derivatives |
EP0368160A1 (en) * | 1988-11-08 | 1990-05-16 | MERCK PATENT GmbH | Tetralin derivatives |
EP0376824A1 (en) * | 1988-12-26 | 1990-07-04 | Elf Sanofi | Process for the preparation of chroman derivatives and synthesis intermediates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839346A (en) * | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
-
1991
- 1991-11-19 EP EP19910119718 patent/EP0489300A3/en not_active Ceased
- 1991-12-02 US US07/801,000 patent/US5208246A/en not_active Expired - Fee Related
- 1991-12-04 CA CA002056922A patent/CA2056922A1/en not_active Abandoned
- 1991-12-05 JP JP3321840A patent/JPH07113014B2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0168619A1 (en) * | 1984-06-12 | 1986-01-22 | Beecham Group Plc | N-acylated di- or tetrahydronaphthalenamines, and antihypertensive compositions containing them |
EP0321175A1 (en) * | 1987-12-14 | 1989-06-21 | Beecham Group Plc | Indane derivatives |
EP0368160A1 (en) * | 1988-11-08 | 1990-05-16 | MERCK PATENT GmbH | Tetralin derivatives |
EP0376824A1 (en) * | 1988-12-26 | 1990-07-04 | Elf Sanofi | Process for the preparation of chroman derivatives and synthesis intermediates |
Also Published As
Publication number | Publication date |
---|---|
EP0489300A2 (en) | 1992-06-10 |
JPH04308564A (en) | 1992-10-30 |
US5208246A (en) | 1993-05-04 |
JPH07113014B2 (en) | 1995-12-06 |
CA2056922A1 (en) | 1992-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL89509A0 (en) | Breach-cooled structure | |
GB2224046B (en) | Toilet assembly | |
ZA912572B (en) | Phosphonopeptides with collagenase inhibiting activity | |
GB9026268D0 (en) | Kerbing structure | |
EP0423928A3 (en) | Multi-ferrule structure | |
EP0446706A3 (en) | Peptides with tachykinin-agonistic or -antagonistic activity | |
GB8808368D0 (en) | Arrangement including moveable tower | |
EP0489300A3 (en) | New tetralones with pharmacological activity | |
GB9027564D0 (en) | Microlaminated structure | |
ZA912574B (en) | Phosphonopeptides with collagenase inhibiting activity | |
EP0444706A3 (en) | Aryl-propyl-amines having antifungal activity | |
GB9013147D0 (en) | Structure | |
GB2224298B (en) | Roller mounting | |
IL98754A0 (en) | Anti-metastatic factor | |
HU9400574D0 (en) | Composition with adaptogenic activity | |
GB8929254D0 (en) | A structure | |
GB2263485B (en) | Knitted structure | |
KR960007663Y1 (en) | Cathode structure | |
IL89955A0 (en) | Ornamental design structure | |
GB9022935D0 (en) | Office structure | |
GB2225035B (en) | Construction assemblies | |
HUT60012A (en) | Height-limiting structure | |
PL288257A1 (en) | Continuous structure | |
GB8828727D0 (en) | Neutrophil-stimulating activity i | |
GB2226491B (en) | Tank-flushing assemblies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19930414 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 19960226 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 19960817 |